Actively Recruiting
The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament
Led by British University In Egypt · Updated on 2025-05-30
48
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized clinical trial is to evaluate the capability of the material to exert bacterial reduction of diclofenac sodium versus of that calcium hydroxide paste when these materials are used as intracanal medications in permanent molar teeth with chronic apical periodontitis. The main question\[s\] it aims to answer are: • Will the diclofenac sodium (NSAIDs) possess antimicrobial efficacy to be used effectively as an intracanal medicament similar to that of calcium hydroxide in primary endodontic treatment? Participants will be allocated randomly into three equal groups by using computer generated randomization, according to the type of intracanal medication.
CONDITIONS
Official Title
The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with teeth diagnosed with apical periodontitis
- Periapical Index (PAI) 65 2
- The teeth are restorable
You will not qualify if you...
- Teeth with immature roots
- Non restorable teeth
- Medically compromised patients with systemic complication that would alter the treatment
- Teeth with internal/external root resorption
- Patient with an allergy to diclofenac sodium
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
British university in Egypt
Cairo, Egypt
Actively Recruiting
Research Team
S
Summer M Elsayed, Bachelor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here